Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:1031 Refacto FVIII Assay
Search Links: General Info : Protocols : Patient Info

DescriptionOne stage factor assay for Refacto FVIII
IndicationTo monitor treatment for haemophilia A patients (FVIII deficiency) for those patients specifically treated with Refacto concentrate
Additional InfoUses an APTT based clotting method to perform a one stage factor assay against a Refacto standard rather than human FVIII. Treatment assays done at LGI and SJUH.
Concurrent TestsCoagulation screen
Dietary Requirementsna

InterpretationNot reported against a Normal range as NOT used for diagnostic purposes only used to monitor treatment of concentrate

Ref. Range (Male) See Comment
Ref. Range (Female) See Comment
Ref. Range (Paed) See Comment
Ref. Range NotesPlease note this test is NOT reported against a Normal range as it is used to monitor treatment only, not as a diagnostic test Critical telephone values: Not a diagnostic test
Unitsiu/dL

Other Help:National Laboratory Medicine Handbook

IP Acute TAT** Contact Laboratory before requesting **
IP Routine TAT5 days
GP Acute TAT** Contact Laboratory before requesting **
GP Routine TAT5 days
Turnround CommentNA
Originally edited by : na. Last edited on 18/06/2019 10:38:12. Published By on 18/06/2018 10:38:12.